Twitter-Delivered CME/CE on
Chronic Kidney Disease from @ckd_ce
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. This is particularly important in the care of patients with or at risk for CKD, as this has become a multidisciplinary and interprofessional focus. Kidney health is now linked not only pathophysiologically but also by treatment strategies that target diverse cardiovascular outcomes as well as renal health. These issues are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Genetic Spectrum of CAKUT in Chinese Newborns
2) Our guest faculty is M Abdul Qader🇧🇩@md_abdulqader83, Pediatric #Nephrologist @squarehospital and Clinical Fellow #NUH, #Singapore.This program...
Putative and Potential Markers of IgAN
2) Our guest faculty is @DrPallaviPrasad Assistant Prof Nephrology @SJHDelhi, India. This program is part of a foundational 🫘 #MedEd #accredited...
High-Target HDF Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE RCT
2a) Faculty disclosures are listed at https://t.co/PHlIppl6Yw. There was no industry support for this program. Please also check out, for more...
Anticoagulant-Related Nephropathy
2) Our guest author is Isha Tiwari MD DM @nephronishaOur topic for 🆓 CE/#CME : #ARN - Anticoagulant Related Nephropathy#MedTwitter #nephtwitter...
Longer-Term Clinical Outcomes of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative Recipients
2) Our returning guest author is @happiedocOur topic for 🆓 CE/#CME: Longer-Term Clinical Outcomes From the #THINKER and #EXPANDER Trials of...
TRPC6 Inhibitor Study Design for FSGS
1b) Our topic for🆓CE/#CME : #FSGS and BI 764198, a selective oral #TRPC6 inhibitor. You can learn more about FSGS here: https://t.co/dcHRskjRwL by...
The KFRE and How It Is Used
1b) Faculty disclosures are listed at https://t.co/PHlIppl6Yw. Please also check out, for more 🆓credit, the #blogposts edited by @sophia_kidney at...
ASN-IgAN Highlights
2) @IgAN_JBarratt attended #KidneyWk 2023 and collected the best #IgAN highlights to share with our followers and learners here on @ckd_ce, your...
Clinical Trial Update & Potential Clinical Applications for HIF-PHI Therapeutics for Patients on Hemodialysis for CKD
1b) Our expert guest faculty is #nephrologist @DrBobPro1 of @waynemedicine.#nephtwitter @MedTweetorials @ISNkidneycare @goKDIGO @KIRepors. Earn more...
Obesity and CKD: A High-Risk Combination
1b) Our topic for🆓CE/#CME : #Obesity and #CKD!#MedTwitter #nephtwitter @ISNkidneycare #FOAMedFollow this 🧵 for 0.5hr 🆓CE/#CME, and follow @ckd_ce...
@CKD_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @ckd_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.